OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(13E)-16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4
1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
15-methyl-heptadecanoic acid
16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4
2-[(2S,4aR,12aS)-8-[(2-chlorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-morpholin-4-ylpropyl)acetamide
2-[(2S,4aR,12aS)-8-[(2-fluorophenyl)carbamoylamino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-deoxy-2-fluoro-alpha-D-mannose
3,5-dihydroxyphenylacetyl-CoA
3,5-dihydroxyphenylacetyl-CoA(4-)
3-mercaptolactate-cysteine disulfide
3-mercaptolactic acid-cysteine disulfide
3beta-Hydroxy-7,12-dioxo-5beta-cholan-24-oic Acid
7,12-dioxolithocholate
7,12-dioxolithocholic acid
ardisimamiloside E
benzonatate
ethyl-4-aminobutyrate
Lithocarol A
Mafenide
Mafenide acetate
Mafoprazine mesylate
N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3S,4S,5S,6R)-6-[[(2S,3S,4S,5S,6R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-[[(2R,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]acetamide
N-[(3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3S,4S,5S,6R)-6-[[(2S,3S,4S,5S,6R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-[[(2R,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]acetamide
ocfentanyl
Officinoic acid B
PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
PE(0:0/16:1(9Z))
CL: Cell Ontology
border associated macrophage (Mmus)
EFO: Experimental Factor Ontology
bipolar disorder
C-Maf-inducing protein
C-Maf-inducing protein (human)
Duane retraction syndrome 3 with or without deafness
level of C-Maf-inducing protein (human) in cerebrospinal fluid
level of C-Maf-inducing protein in blood
level of C-Maf-inducing protein in blood serum
level of transcription factor MafG (human) in cerebrospinal fluid
level of transcription factor MafG in blood serum
MAF
Maffucci syndrome
MAFG (human)
transcription factor MafG
transcription factor MafG (human)
vitamin D-binding protein (human)
GO: Molecular Function
protein serine/threonine kinase activity
HP: Human Phenotype
Capillary malformation
OBA: Ontology of Biological Attributes
level of C-Maf-inducing protein in blood
level of C-Maf-inducing protein in blood serum
level of transcription factor MafG in blood serum
RDO: RGD Disease Ontology
Ayme-Gripp syndrome
bipolar I disorder
bipolar ll disorder
cataract 21 multiple types
Duane retraction syndrome 3
Maffucci syndrome
Major Affective Disorder 3
Major Affective Disorder 4
Major Affective Disorder 5
Major Affective Disorder 6
Major Affective Disorder 7
Major Affective Disorder 8
Major Affective Disorder 9
metabolic dysfunction-associated steatotic liver disease
multicentric carpotarsal osteolysis syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



















